ReviewEuropean cardiology2026

Beyond Traditional Lipid Lowering: Obicetrapib and the Renaissance of Cholesteryl Ester Transfer Protein Inhibition.

Prashant Thandi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.